Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Darwin Global Management, Ltd. | 3.06M | $456.0M | 7.77% | +29.7K | 2026-03-31 |
| Paradigm Biocapital Advisors LP | 1.11M | $177.0M | 2.83% | -- | 2026-03-31 |
| UBS Group AG | 768.4K | $122.0M | 1.95% | +639.6K | 2026-03-31 |
| RTW INVESTMENTS, LP | 715.3K | $114.0M | 1.82% | -- | 2026-03-31 |
| MILLENNIUM MANAGEMENT LLC | 570.1K | $90.0M | 1.45% | +11.2K | 2026-03-31 |
| Holocene Advisors, LP | 494.5K | $78.0M | 1.26% | +410.4K | 2026-03-31 |
| EVENTIDE ASSET MANAGEMENT, LLC | 357.6K | $57.0M | 0.91% | -25.4K | 2026-03-31 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 304.0K | $48.0M | 0.77% | +70.2K | 2026-03-31 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 281.8K | $44.0M | 0.72% | -- | 2026-03-31 |
| MORGAN STANLEY | 201.4K | $32.0M | 0.51% | +173.4K | 2026-03-31 |
